BAY-293

N/A

Report date: 2023/12/13 15:50:47

Base Information

Drug NameBAY-293
Drug Alias NameSOS1 inhibitor therapy(Bayer)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSon of sevenless homolog 1 inhibitors
TargetsSon of sevenless homolog 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer AG
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A